Form 4: Femasys Director Edward Uzialko Granted 17,600 Stock Options

Femasys Inc. Director Edward R. Uzialko was granted 17,600 stock options with an exercise price of $0.98 per share, vesting one year from the grant date.

Summary

• Edward R. Uzialko, a Director of Femasys Inc. (FEMY), was the reporting person for this SEC Form 4 filing.
• On June 25, 2025, Mr. Uzialko acquired 17,600 stock options.
• The exercise price for these options is $0.98 per share.
• The options are for Common Stock, with 17,600 shares underlying the options.
• The shares underlying the stock option will vest one year from the grant date, specifically on June 25, 2026, contingent upon continued service.
• The expiration date for these stock options is June 25, 2035.
• Following this transaction, Mr. Uzialko beneficially owns 17,600 derivative securities directly.

Sentiment

Score: 6

Explanation: Slightly positive, as it represents a routine compensation event that aligns director interests with shareholders, without indicating any negative operational or financial news.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, as the options gain value if the company's stock price increases.
• The options were granted at an exercise price of $0.98, which could incentivize the director to contribute to the company's growth.

Future Outlook

The document indicates that the granted stock options will vest one year from the grant date, contingent on the director's continued service, providing a future incentive for the director.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transaction, common across all industries as part of executive and director compensation packages. It does not provide broader industry trends or competitive insights.

Related Party Transactions

• The grant of 17,600 stock options to Edward R. Uzialko, a Director of Femasys Inc., constitutes a related-party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant of stock options to a director can be viewed positively as it aligns the director's financial incentives with the company's stock performance, potentially encouraging decisions that enhance shareholder value.

Next Steps

• The stock options are scheduled to vest on June 25, 2026, provided the director's continued service.

Key Dates

Keywords

Femasys Inc., FEMY, SEC Form 4, Insider Transaction, Stock Option Grant, Beneficial Ownership, Director Compensation, Equity Compensation